Pluri Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Pluri Inc. (PLUR) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.80 million for the 6-month period ending 2018-12-31, per its 10-Q filed 2019-02-06.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-06
- Pluri Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$10.23M.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $8.43M, a 31.41% decline year-over-year.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $2.88M.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$2.65M.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $4.11M.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$1.52M.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$16.40M, a 190.46% decline from fiscal 2015.
- Pluri Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $18.13M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | -$10.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | -$1.80M 10-Q · filed 2019-02-06 | $1.08M derived: sum of 3 quarters · filed 2019-02-06 | -$1.56M derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2018-09-30 | $8.43M 10-Q · filed 2018-11-07 | $11.31M derived: sum of 2 quarters · filed 2018-11-07 | $8.67M derived: sum of 3 quarters · filed 2018-11-07 | $253.00K derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2018-06-30 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $233.00K derived: sum of 2 quarters · filed 2018-09-12 | -$8.18M derived: sum of 3 quarters · filed 2019-02-06 | $4.11M 10-K · filed 2018-09-12 | ||
| 2018-03-31 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$11.06M derived: sum of 2 quarters · filed 2019-02-06 | $1.23M 10-Q · filed 2018-05-09 | $621.00K derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-12-31 | -$8.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $3.88M 10-Q · filed 2019-02-06 | $3.87M 10-Q · filed 2018-02-06 | $3.27M derived: sum of 3 quarters · filed 2019-02-06 | $1.25M derived: sum of 4 quarters · filed 2019-02-06 | |
| 2017-09-30 | $12.29M 10-Q · filed 2018-11-07 | $7.59M 10-Q · filed 2017-11-07 | $11.68M derived: sum of 2 quarters · filed 2018-11-07 | $9.67M derived: sum of 3 quarters · filed 2018-11-07 | $10.90M derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | -$612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | -$2.63M derived: sum of 2 quarters · filed 2018-09-12 | -$1.39M derived: sum of 3 quarters · filed 2018-09-12 | -$1.52M 10-K · filed 2018-09-12 | ||
| 2017-03-31 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$779.00K derived: sum of 2 quarters · filed 2018-05-09 | -$904.00K 10-Q · filed 2018-05-09 | -$85.00K derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-12-31 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $1.11M 10-Q · filed 2018-02-06 | $1.93M derived: sum of 3 quarters · filed 2018-09-12 | $2.39M derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-09-30 | -$125.00K 10-Q · filed 2017-11-07 | $694.00K derived: sum of 2 quarters · filed 2018-09-12 | $1.15M derived: sum of 3 quarters · filed 2018-09-12 | -$4.71M derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-06-30 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $1.27M derived: sum of 2 quarters · filed 2018-09-12 | -$4.58M derived: sum of 3 quarters · filed 2018-09-12 | -$16.40M 10-K · filed 2018-09-12 | ||
| 2016-03-31 | $456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$5.40M derived: sum of 2 quarters · filed 2017-05-08 | -$17.22M 10-Q · filed 2017-05-08 | -$3.54M derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-12-31 | -$5.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$17.68M 10-Q · filed 2017-02-08 | -$4.00M derived: sum of 3 quarters · filed 2017-09-07 | -$2.01M derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-09-30 | -$11.82M 10-Q · filed 2016-11-07 | $1.86M derived: sum of 2 quarters · filed 2017-09-07 | $3.84M derived: sum of 3 quarters · filed 2017-09-07 | $5.14M derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-06-30 | $13.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $15.66M derived: sum of 2 quarters · filed 2017-09-07 | $16.96M derived: sum of 3 quarters · filed 2017-09-07 | $18.13M 10-K · filed 2017-09-07 | ||
| 2015-03-31 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $3.28M derived: sum of 2 quarters · filed 2016-05-09 | $4.45M 10-Q · filed 2016-05-09 | $5.31M derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-12-31 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $2.47M 10-Q · filed 2016-02-08 | $3.32M derived: sum of 3 quarters · filed 2016-09-07 | $2.33M derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-09-30 | $1.17M 10-Q · filed 2015-11-05 | $2.02M derived: sum of 2 quarters · filed 2016-09-07 | $1.04M derived: sum of 3 quarters · filed 2016-09-07 | -$2.94M derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-06-30 | $855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | -$133.00K derived: sum of 2 quarters · filed 2016-09-07 | -$4.11M derived: sum of 3 quarters · filed 2016-09-07 | -$4.51M 10-K · filed 2016-09-07 | ||
| 2014-03-31 | -$988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | -$4.96M derived: sum of 2 quarters · filed 2015-05-06 | -$5.37M 10-Q · filed 2015-05-06 | -$24.18M derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-12-31 | -$3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$4.38M 10-Q · filed 2015-02-05 | -$23.20M derived: sum of 3 quarters · filed 2015-09-09 | -$18.92M derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-09-30 | -$404.00K 10-Q · filed 2014-11-06 | -$19.22M derived: sum of 2 quarters · filed 2015-09-09 | -$14.95M derived: sum of 3 quarters · filed 2015-09-09 | -$30.15M derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-06-30 | -$18.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | -$14.54M derived: sum of 2 quarters · filed 2015-09-09 | -$29.74M derived: sum of 3 quarters · filed 2015-09-09 | -$382.00K 10-K · filed 2015-09-09 | ||
| 2013-03-31 | $4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-08 | -$10.93M derived: sum of 2 quarters · filed 2014-05-08 | $18.43M 10-Q · filed 2014-05-08 | $16.22M derived: sum of 4 quarters · filed 2014-09-11 | ||
| 2012-12-31 | -$15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $14.16M 10-Q · filed 2014-02-05 | $14.16K 10-Q · filed 2013-01-31 | $11.94M derived: sum of 3 quarters · filed 2014-09-11 | -$19.24M derived: sum of 4 quarters · filed 2014-09-11 | |
| 2012-09-30 | $29.36M 10-Q · filed 2013-11-05 | $27.15M derived: sum of 2 quarters · filed 2014-09-11 | -$4.04M derived: sum of 3 quarters · filed 2014-09-11 | $25.12M derived: sum of 4 quarters · filed 2014-09-11 | ||
| 2012-06-30 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | -$33.40M derived: sum of 2 quarters · filed 2014-09-11 | -$4.24M derived: sum of 3 quarters · filed 2014-09-11 | -$33.44M 10-K · filed 2014-09-11 | ||
| 2012-03-31 | -$31.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$2.03M derived: sum of 2 quarters · filed 2013-05-08 | -$31.22M 10-Q · filed 2013-05-08 | -$33.26M derived: sum of 4 quarters · filed 2013-09-11 | ||
| 2011-12-31 | $29.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | -$36.16K 10-Q · filed 2013-01-31 | -$36.16M 10-Q · filed 2012-02-09 | -$2.07M derived: sum of 3 quarters · filed 2013-09-11 | $38.05M derived: sum of 4 quarters · filed 2013-09-11 | |
| 2011-09-30 | -$29.20M 10-Q · filed 2012-11-06 | -$31.23M derived: sum of 2 quarters · filed 2013-09-11 | $8.89M derived: sum of 3 quarters · filed 2013-09-11 | $12.51M derived: sum of 4 quarters · filed 2013-09-11 | ||
| 2011-06-30 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $38.09M derived: sum of 2 quarters · filed 2013-09-11 | $41.70M derived: sum of 3 quarters · filed 2013-09-11 | $41.25M 10-K · filed 2013-09-11 | ||
| 2011-03-31 | $40.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $43.74M derived: sum of 2 quarters · filed 2012-05-08 | $43.28M 10-Q · filed 2012-05-08 | |||
| 2010-12-31 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $3.16M 10-Q · filed 2012-02-09 | ||||
| 2010-09-30 | -$456.00K 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$756.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |